In the treatment of glaucoma, maintaining adherence to eye drops is a constant struggle for patients. Shifts in clinical guidelines in both the UK and EU have moved the field towards SLT treatment as a frontline option. Belkin Vision’s new, intuitive DSLT system is designed to benefit both patients and clinicians through its ease of use, careful design, and speed. All of this means that patients can be treated more quickly, and clinicians can be freed up from older systems.
Soar Like an Eagle
Belkin’s new DLST system represents an important step in the move from “drops first” to “laser first”
Sponsored By Belkin Vision
10/13/2022
1 min read
